Anti-helicobacter vaccine composition comprising a th1 adjuvant

Details Anti-helicobacter vaccine composition comprising a th1 adjuvant Anti-helicobacter vaccine composition comprising a th1 adjuvant

A - Human Necessities

61

K

A61K 39/106 (2006.01) A61K 39/39 (2006.01)

Patent

CA 2287976

The invention concerns the use of an immunogenic agent derived from Helicobacter, associated with an adjuvant such as QS-21, DC-chol or Bay R1005, for making a pharmaceutical composition designed to induce an immune response of the T helper 1 type (Th1), for preventing or treating Helicobacter infection in a mammal.

L'invention a pour objet l'usage d'un agent immunogène dérivé d'Helicobacter, en association avec un adjuvant tel que le QS-21, le DC-chol ou le Bay R1005, dans la fabrication d'une composition pharmaceutique destinée à l'induction d'une réponse immune de type T helper 1 (Th1) à l'encontre d'Helicobacter, pour prévenir ou traiter une infection à Helicobacter chez un mammifère.

Affiliated with

Also associated with

Rating

Anti-helicobacter vaccine composition comprising a th1 adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-helicobacter vaccine composition comprising a th1 adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-helicobacter vaccine composition comprising a th1 adjuvant will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1940547